Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. A review

Neurotoxicity Research

Volumn 5, Issue 6, 2003, Pages 375-383

  Kostrzewa, Richard M ^a   Segura Aguilar, Juan ^b  

^a East Tennessee State University   (United States)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Alzheimer disease; Astroglia; Cell cycle genes; Cytokines; Human umbilical cord blood; Neurodegeneration; Neuroprotection; Non neural transplantation; Oligodendrocytes; Sertoli cells

Indexed keywords

NEUROPROTECTIVE AGENT; XENOBIOTIC AGENT;

ALZHEIMER DISEASE; ANIMAL; CELL TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; INFLAMMATION; METABOLISM; NERVE DEGENERATION; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; REVIEW; SYNAPSE;

ALZHEIMER DISEASE; ANIMALS; CELL TRANSPLANTATION; HUMANS; INFLAMMATION; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OXIDATIVE PHOSPHORYLATION; SYNAPSES; XENOBIOTICS;

EID: 1342269759     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033166     Document Type: Review

References (93)

1. Alberati-Giani D, P Ricciardi-Castagnoli, C Köhler and AM Cesura (1996) Regulation of the kynurenine metabolic pathway by interferon-γ inmurine cloned macrophages and microglial cells. J. Neurochem. 66, 996-1004.
2. Andersen JK (2003) Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease Neurotox. Res. 5, 307-314.
3. Archer T, T Palomo and A Fredriksson (2002a) Functional deficits following neonatal dopamine depletion and isolation housing: Circular water maze acquisition under pre-exposure conditions andmotor activity. Neurotox. Res. 4, 503-522.
4. Archer T, T Palomo and A Fredriksson (2002b) Neonatal 6-hydroxydopamine-induced hypo/hyperactivity: Blockade by dopamine reuptake inhibitors and effect of acute d-amphetamine. Neurotox. Res. 4, 247-266.
5. Bakker JM, F van Bel and CJ Heijnen (2001) Neonatal glucocorticoids and the developing brain: Short-term treatment with life-long consequences? Trends Neurosci. 24, 649-653.
6. Barcia C, E Fernández-Villalba, JM Navarro-Ruiz, V Garcia, JL Saez-Cassanelli and MT Herrero (2002a) Active cytokines in chronic parkinsonian monkeys one year after last MPTP exposure. Clinical and post-mortem study. Soc. Neurosci. Abstr. 485.16.
7. Barcia C, A Sánchez-Babillo, V Bautista-Hernández, JM Navarro-Ruiz, E Fernández-Villalba, B Faucheux, EC Hirsch and MT Herrero (2002b) Blood vessels and neurodegeneration in Parkinson's disease. Study in chronic MPTP-treated monkeys, In: Nicholson and Faull (Eds.), The Basal Ganglia VII (Kluwer Academic/Plenum Publishers, New York), pp. 341-347.
8. Barcia C, AF Barreiro, M Poza and MT Herrero (2003) Parkinson's disease and inflammatory changes. Neurotox. Res. 5, 411-418.
9. 4 receptor in a mouse cerebral cortex neuronal cell line. Neurotox. Res. 5(5), 369-374.
10. Belluardo N, G Mudo, M Blum and K Fuxe (2000) Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res. 113, 21-34.
11. Barros VG, LA Boado, AM Adamo, R Caviedes, P Caviedes and MC Antonelli (2003) Corticosterone down-regulates dopamine D(4) receptor in a mouse cerebral cortex neuronal cell line. Neurotox. Res. 5, 369-374.
12. Beninger RJ, A Jhamandas, H Aujla, L Xue, RV Dagnone, RJ Boegman and K Jhamandas (2002) Neonatal exposure to the glutamate receptor antagonist MK-801: Effects on locomotor activity and pre-pulse inhibition before and after sexual maturity in rats. Neurotox. Res. 4, 477-488.
13. Bickness AR, HS Goodwin, CO Quinn and CD Verneake (2002) Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplantation 11(3), 261-264.
14. 2 agonist-enhancement of locomotor activity in 6-hydroxy-dopamine-lesioned rats. Neurotox. Res. 5, 329-338.
15. Bus JS and JE Gibson (1984) Paraquat: Model for oxidant-initiated toxicity. Environ. Health Perspect. 55, 37-46.
16. Buzanska L, EK Machaj, B Zablocka, Z Pojda and K Domanska-Janik (2002) Human cord blood-derived cells attain neuronal and glial features in vitro. J. Cell Sci. 115(Part 10), 2131-2138.
17. Cárdenas AM, MP Rodriguez, MP Cortes, RM Alvarez, W Eei, SI Rapoport, T Shimahara, R Caviedes and P Caviedes (1999) Calcium signals in cell lines derived from the cerebral cortex of normal and trisomy 16 ice. NeuroReport 10, 363-369.
18. Castellsague X, N Munoz, E DeStephani, CG Victora, R Castellotto, PA Rolon and MJ Quintana (1999) Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int. J. Cancer 82, 657-664.
19. Chen J, PR Sanberg, Y Li, L Wang, M Lu, AE Willing, J Sanchez-Ramos and M Chopp (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688.
20. Chiueh CC, T Andoh, AR Lai, E Lai and G Krishna (2000) Neuroprotective strategies in Parkinson's disease: Protection against progressive nigral damage induced by free radicals. Neurotox. Res. 2, 293-310.
21. Dajas F, F Rivera, F Blasina, F Arredondo, C Echeverry, L Lafon, A Morquio and H Heizen (2003) Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox. Res. 5, 425-432.
22. Double KL, M Gerlach, V Schunemann, AX Trautwein, L Zecca, M Gallorini, MB Youdim, P Riederer and D Ben-Shachar (2003) Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem. Pharmacol. 66, 489-494.
23. Forstedt-Wallin B, J Lundström, G Fredriksson, R Schwarcz and J Luthman (1999) 3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631. Eur. J. Pharmacol. 386, 15-24.
24. Fredriksson A and T Archer (2003) Hyperactivity following postnatal NMDA antagonist treatment: Reversal by d-amphetamine. Neurotox. Res. 5, (in-press).
25. Fredriksson A, N Schroder and T Archer (2003) Neurobehavioural deficits following postnatal iron overload: 1 Spontaneous motor activity. Neurotox. Res. 5(1-2), 53-76.
26. 1 during programmed cell death. Neuron 12, 343-355.
27. Garbuzova-Davis S, A Willing, T Zigova, S Saporta, EB Justen, JC Lane, JE Hudson, N Chen, CD Hart and PR Sanberg (2003) Intravenous administration of human umbilical cord blood cells in a mouse model of ALS: Distribution, migration and differentiation. J. Hematother and Stem Cell Res. 12, 255-270.
28. Gerlach M, KL Double, MBH Youdim and P Riederer (2000) Strategies for the protection of dopaminergic neurons against neurotoxicity. Neurotox. Res. 2, 99-114.
29. 1 receptors in neonatal 6-OHDA-lesioned rats. Dev. Brain Res. 76, 59-65.
30. 1 receptor mRNA levels: Absence of other neurochemical associateions with the enhanced behavioral responses of lesioned rats. J. Neurochem. 63, 1282-1290.
31. Guillemin GJ, DG Kerr, GA Smythe, V Kapoor, PJ Armati and BJ Brew (2000) Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. Redox Report 5, 108-111.
32. +-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity. Neurotox. Res. 5, 407-410.
33. +-ATPase. Neurosci. Lett. 138, 188-192.
34. Hirsch EC, S Hunot, P Damier and B Faucheux (1998) Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration? Ann. Neurol. 44, 115-120.
35. Iqbal K, C Alonso Adel, E El-Akkad, CX Gong, N Haque, S Khatoon, I Tsujio and I Grundke-Iqbal (2002) Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration. J. Neural Transm. Suppl. 62, 309-319.
36. Kihara T, S Shimohama, H Sawada, J Kimura, T Kume, H Kochiyama, T Maeda and A Akaike (1997) Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann. Neurol. 42, 159-163.
37. 2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity. Brain Res. 792, 331-334.
38. Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19, 1-17.
39. Kostrzewa RM (2000) Review on apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease. Neurotox. Res. 2, 239-250.
40. Kostrzewa RM, R Brus, M Rykaczewska and A Plech (1993) Low dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats. Pharmacol. Biochem. Behav. 44, 487-489.
41. 2 agonist priming in intact and dopamine-lesioned rats: Implications for motor dyskinesias. Neurotox. Res. 6 (in press)
42. Kurkowska-Jastrzebska I, A Wronska, M Kohutnicka, A Czlonkowski and A Czlonkowska (1999) The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 156, 50-61.
43. Langston JW, P Ballard, JW Tetrud and I Irwin (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
44. Langston JW, LS Forno, J Tetrud, AG Reeves, JA Kaplan and D Karluk (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46, 598-605.
45. Levites Y, T Amit, MBH Youdim and S Mandel (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin-3-gallate neuroprotective action. J. Biol. Chem. 277, 30574-30580.
46. Lima ACP, PR Louzada, FG De Mello and ST Ferreira (2003) Neuroprotection against Aß and glutamate toxicity by melatonin: Are GABA receptors involved? Neurotox. Res. 5(5), 323-328.
47. Loughlin AJ, MN Woodroofe and ML Cuzner (1993) Modulation of interferon-γ-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-β 1, interleukin-4, noradrenaline and glucocorticoids. Immunology 79, 125-130.
48. Mandel S, L Reznichenko, T Amit and MBH Youdim (2003) Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt Pathway. Neurotox. Res. 5, 419-424.
49. Marsden CD (1983) Neuromelanin and Parkinson's disease. J. Neural Transm. Suppl. 19, 121-141.
50. Martinez-Palma L, M Pehar, P Cassina, H Peluffo, R Castellanos, G Anesetti, JS Beckman and L Barbeito (2003) Involvement of nitric oxide on kainite-induced toxicity in oligodendrocyte precursors. Neurotox. Res. 5, 399-406.
51. Matute C, MV Sánchez-Gomez, L Martinez-Millán and R Miledi (1997) Glutamate receptor mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. USA 94, 8830-8835.
52. McDonald JW, SP Althomsons, KL Hyre, DW Choi and ME Goldberg (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Med. 4, 291-297.
53. McGeer PL, S Itagaki, BE Boyes and EG McGeer (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
54. McCormack AL, M Thiruchelvam, AB Manning-Bog, C Thiffault, JW Langston, DA Cory-Slechta and DA DiMonte (2002) Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10 119-127.
55. 1 in mouse dentate gyrus following TMT-induced hippocampal damage. Neurotox. Res. 5(5), 339-354.
56. 3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpa 7, or α 6 subunit mRNA: An autoradiography and in situ hybridization study in rat brain. Neuroscience 16, 1633-1646.
57. Newman MB, CD Davis, N Kuzmin-Nichols and PR Sanberg (2003) Human umbilical cord blood (HUCB) cells for central nervous system repair. Neurotox. Res. 5(5), 355-368.
58. Nilsberth C, B Kostyszyn and J Luthman (2002) Changes in APP, PSI and other factors related to Alzheimer's disease pathophysiology after trimethyltin-induced brain lesion in the rat. Neurotox. Res. 4, 625-636.
59. Nowak P, R Brus and RM Kostrzewa (2001) Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol. J. Pharmacol. 53, 319-329.
60. Olney JW, DF Wozniak, V Jevtovic-Todorovic, NB Farber, P Bittigau and C Ikonomidou (2002) Glutamate and GABA receptor dysfunction in the fetal alcohol syndrome. Neurotox. Res. 4, 315-325.
61. Olson J, S Sabreo and U Fasting (1985) Interaction of alcohol and tobacco as risk factors in cancer of the laryngeal region. J. Epidemiol. Community Health 39, 165-168.
62. Oświȩimska J, R Brus, R Szkilnik, P Nowak and RM Kostrzwa (2000) 7-OH-DPAT unlike quinpirole, does not prime a yawning response in rats. Pharmacol. Biochem. Behav., 67, 11-15.
63. Oświȩcimska J, R Brus, R Szkilnik, A Sokola, RM Kostrzewa and J Shani (2001) Sexual differentiation in behavioral patterns of rats, pretreated with two central dopamine agonists: Quinpirole and 7-OH-DPAT. Pharmacol. Rev. Commun. 11, 203-213.
64. Park DS, EJ Morris, LA Greene and HM Geller (1997) G1/S cell cycle blockers and inhibition of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17, 1256-1270.
65. Park DA, A Obeidat, A Giovanni and LA Greene (2000) Cell cycle regulators in neuronal death evoked by excitotoxic stress: Implications for neurodegeneration and its treatment. Neurobiol. Aging 21, 771-781.
66. Purdon AD and SI Rapoport (1998) Energy requirements for two aspects of phospholipids metabolism in mammalian brain. Biochem. J. 335, 313-318.
67. Radesäter A-C, S Johansson, C Öberg and J Luthman (2003) The vitamin-E analog trolox and the NMDA antagonist MK-801 protect pyramidal neurons in hippocampal slice cultures from IL-1β-induced neurodegeneration. Neurotox. Res. 5, 433-442.
68. Rapoport SI (2003) Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease. Neurotox. Res. 5, 385-396.
69. Rapoport SI, K Hatanpää, DR Brady and K Chandrasekaran (1996) Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease. Neurodegeneration 5, 473-476.
70. Rodriguez AI, AE Willing, DF Cameron, S Saporta and PR Sanberg (2002) Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum. Neurotox. Res. 4, 103-109.
71. Rodriguez AI, AE Willing, S Saporta, DF Cameron and PR Sanberg (2003) Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: A preliminary study. Neurotox. Res. 5, 443-450.
72. Rojas-Fernandez CM, M Chen and HL Fernandez (2002) Implications of amyloid precursor protein and subsequent β-amyloid production to the pharmacotherapy of Alzheimer's disease. Pharmacotherapy 22, 1547-1563.
73. Rosenberg PA, W Dai, XD Gan, S Ali, J Fu, SA Back, RM Sanchez, MM Segal, PL Follett, FE Jensen and JJ Volpe (2003) Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J. Neurosci. Res. 71, 237-245.
74. Rothwell NJ and GN Luheshi (2000) Interleukin-1 in the brain: Biology, pathology and therapeutic target. TINS 23, 618-625.
75. Sanberg PR, AE Willing and DW Cahill (2002) Novel cellular approaches to repair of neurodegenerative disease: From Sertoli cells to umbilical cord blood stem cells. Neurotox. Res. 4, 95-101.
76. Sanchez-Ramos JR, S Song, SG Kamath, T Zigova, A Willing, F Cardozo-Pelaez, T Stedefor, M Chopp and PR Sanberg (2001) Expression of neural markers in human umbilical cord blood. Exp. Neurol. 171, 109-115.
77. Saporta S, JJ Kim, A Willing, ES Fu, CD Hart and PR Sanberg (2003) Human umbilical cord blood stem cells infusion in spinal cord injury. J. Hematother. and Stem Cell Res. 12, 271-278.
78. Solano F, VJ Herring and JC Garcia-Borron (2000) Neurotoxicity due to o-quinones: Neuromelanin formation and possible mechanisms for oquinone detoxification. Neurotox. Res. 1, 153-169.
79. Sulzer D and L Zecca (2000) Intraneuronal dopamine-quinone synthesis: A review. Neurotox. Res. 1, 181-95.
80. Tan DX, LC Manchester, RJ Reiter, W Qi, SJ Kim and GH El Sokkary (1998) Melatonin protects hippocampal neurons in vivo against kainate induced damage in mice. J. Neurosci. Res. 54, 382-389.
81. Teismann P and B Ferger (2001) Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse 39, 167-174.
82. Teismann P, K Tieu, DK Choi, DC Wu, A Naini, S Hunot, M Vila, V Jackson-Lewis and S Przedborski (2003) Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. USA 100, 5473-5478.
83. Tizabi Y, M Al-Namaeh, KF Manaye and RE Taylor (2003) Protective effects of nicotine on ethanol-induced toxicity in cultured cerebellar granule cells. Neurotox. Res. 5, 315-322.
84. Uversky VN, J Li and AL Fink (2001) Pesticides directly accelerate the rate of α-synuclein fibril formation: A possible factor in Parkinson's disease. FEBS Lett. 500, 105-108.
85. Van Praag HM (2002) Crossroads of corticotrophin releasing hormone. Corticosteroids and monoamines. Neurotox. Res. 4, 531-555.
86. Vitkovic L, JP Konsman, J Bockaert, R Dantzer, V Homburger and C Jacque (2001) Cytokine signals propagate through the brain. Mol. Psychiatry 5, 604-615.
87. Weinreb O, S Mandel and MBH Youdim (2003a) cDNA gene expression profile homology of antioxidants and their anti-apoptotic and pro-apoptotic activities in human neuroblastoma cells. FASEB J. 17(8), 935-937.
88. Weinreb O, S Mandel and MBH Youdim (2003b) Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R -apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate and melatonin. Ann. N.Y. Acad. Sci. 993, 351-361; discussion 387-393.
89. Wilczok T, K Stepien, A Dzierzega-Lecznar, A Zajdel and A Wilczok (1999) Model neuromelanins as antioxidative agents during lipid peroxidation. Neurotox. Res. 1, 141-147.
90. Willing AE, S Saporta, J Lixian, M Milliken, S Poulos, SS Bowersox and PR Sanberg (2002) Preliminary study of the behavioral effects of LBS-neuron implantation on seizure susceptibility following middle cerebral artery occlusion in the rat. Neurotox. Res. 4, 111-118.
91. Zanardi A, G Leo, G Biagini and M Zoli (2002) Nicotine and neurodegeneration in ageing. Toxicol. Lett. 127, 207-215.
92. Zhou FC, Y Sari, T-K Li, C Goodlett and EC Azmitia (2002) Deviations in brain early serotonergic development as a result of fetal alcohol exposure. Neurotox. Res. 4, 337-342.
93. Zigova T, S Song, AE Willing, JE Hudson, MB Newman, S Saporta, J Sanchez-Ramos and PR Sanberg (2001) Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant. 11, 265-274.